Characteristics and cardio-renal outcomes in patients with CKD receiving guideline-directed medical therapy: insights from DISCOVER CKD
GDMT use was associated with reduced adverse renal outcomes in real-world patients with CKD, underscoring the need to address large gaps in GDMT implementation.
Authors
- Eiichiro Kanda (ORCID: https://orcid.org/0000-0003-0676-096X)
- Naoki Kashihara (ORCID: https://orcid.org/0000-0002-9487-984X)
- Steven Fishbane (ORCID: https://orcid.org/0000-0002-2238-8574)
- Carol A. Pollock (ORCID: https://orcid.org/0000-0001-7167-6495)
- Juan José García Sánchez (ORCID: https://orcid.org/0000-0001-6546-7769)
- Krister Järbrink (ORCID: https://orcid.org/0000-0003-2612-1233)
- Roberto Pecoits‐Filho (ORCID: https://orcid.org/0000-0002-0255-6710)
- Richard Ofori‐Asenso (ORCID: https://orcid.org/0000-0002-6643-3269)
- Hungta Chen
- Carolyn S.P. Lam (ORCID: https://orcid.org/0000-0003-1903-0018)
- Surendra Pentakota
Institutions
- AstraZeneca (United Kingdom) (GB)
- The University of Sydney (AU)
- National University of Singapore (SG)
- Pontifícia Universidade Católica do Paraná (BR)
- Kawasaki Medical School (JP)
- Royal North Shore Hospital (AU)
- AstraZeneca (South Korea) (KR)
- National University Heart Centre Singapore (SG)
- AstraZeneca (France) (FR)
- AstraZeneca (Brazil) (BR)
- AstraZeneca (Switzerland) (CH)
- AstraZeneca (Poland) (PL)
- Arbor Research Collaborative for Health (US)
- AstraZeneca (Italy) (IT)
- AstraZeneca (Sweden) (SE)
- National Heart Centre Singapore (SG)
- AstraZeneca (Spain) (ES)
- AstraZeneca (United States) (US)
- Zucker Hillside Hospital (US)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1093/ndt/gfaf175
- Citations
- 1
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- AstraZeneca